ID   PDPK1_HUMAN             Reviewed;         556 AA.
AC   O15530; Q6FI20;
DT   18-OCT-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1998, sequence version 1.
DT   02-NOV-2010, entry version 123.
DE   RecName: Full=3-phosphoinositide-dependent protein kinase 1;
DE            Short=hPDK1;
DE            EC=2.7.11.1;
GN   Name=PDPK1; Synonyms=PDK1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   MEDLINE=97250749; PubMed=9094314; DOI=10.1016/S0960-9822(06)00122-9;
RA   Alessi D.R., James S.R., Downes C.P., Holmes A.B., Gaffney P.R.J.,
RA   Reese C.B., Cohen P.;
RT   "Characterization of a 3-phosphoinositide-dependent protein kinase
RT   which phosphorylates and activates protein kinase B alpha.";
RL   Curr. Biol. 7:261-269(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   MEDLINE=98035195; PubMed=9368760; DOI=10.1016/S0960-9822(06)00336-8;
RA   Alessi D.R., Deak M., Casamayor A., Caudwell F.B., Morrice N.A.,
RA   Norman D.G., Gaffney P.R.J., Reese C.B., MacDougall C.N., Harbison D.,
RA   Ashworth A., Bownes M.;
RT   "3-phosphoinositide-dependent protein kinase-1 (PDK1): structural and
RT   functional homology with the Drosophila DSTPK61 kinase.";
RL   Curr. Biol. 7:776-789(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Myeloid;
RX   MEDLINE=98111410; PubMed=9445477; DOI=10.1126/science.279.5351.710;
RA   Stephens L.R., Anderson K.E., Stokoe D., Erdjument-Bromage H.,
RA   Painter G.F., Holmes A.B., Gaffney P.R.J., Reese C.B., McCormick F.,
RA   Tempst P., Coadwell W.J., Hawkins P.T.;
RT   "Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-
RT   trisphosphate-dependent activation of protein kinase B.";
RL   Science 279:710-714(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF 60-75; 87-100; 184-199; 239-257 AND 284-293,
RP   PHOSPHORYLATION AT SER-241, AND MASS SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RA   Bienvenut W.V., Waridel P., Quadroni M.;
RL   Submitted (MAR-2009) to UniProtKB.
RN   [7]
RP   MUTAGENESIS OF ARG-474, AND ALTERNATIVE SPLICING.
RX   MEDLINE=98301766; PubMed=9637919; DOI=10.1016/S0960-9822(98)70274-X;
RA   Anderson K.E., Coadwell W.J., Stephens L.R., Hawkins P.T.;
RT   "Translocation of PDK-1 to the plasma membrane is important in
RT   allowing PDK-1 to activate protein kinase B.";
RL   Curr. Biol. 8:684-691(1998).
RN   [8]
RP   PHOSPHORYLATION AT SER-25; SER-241; SER-393; SER-396 AND SER-410, AND
RP   MUTAGENESIS OF SER-25; SER-241; SER-393; SER-396 AND SER-410.
RX   MEDLINE=99386657; PubMed=10455013; DOI=10.1042/0264-6021:3420287;
RA   Casamayor A., Morrice N.A., Alessi D.R.;
RT   "Phosphorylation of Ser-241 is essential for the activity of 3-
RT   phosphoinositide-dependent protein kinase-1: identification of five
RT   sites of phosphorylation in vivo.";
RL   Biochem. J. 342:287-292(1999).
RN   [9]
RP   MUTAGENESIS OF ALA-277.
RX   MEDLINE=99292684; PubMed=10364160;
RA   Paradis S., Ailion M., Toker A., Thomas J.H., Ruvkun G.;
RT   "A PDK1 homolog is necessary and sufficient to transduce AGE-1 PI3
RT   kinase signals that regulate diapause in Caenorhabditis elegans.";
RL   Genes Dev. 13:1438-1452(1999).
RN   [10]
RP   PHOSPHORYLATION AT TYR-9; SER-241; TYR-373 AND TYR-376, AND
RP   MUTAGENESIS OF TYR-9; TYR-373 AND TYR-376.
RX   MEDLINE=21463095; PubMed=11481331; DOI=10.1074/jbc.M105916200;
RA   Park J., Hill M.M., Hess D., Brazil D.P., Hofsteenge J.,
RA   Hemmings B.A.;
RT   "Identification of tyrosine phosphorylation sites on 3-
RT   phosphoinositide-dependent protein kinase-1 (PDK1) and their role in
RT   regulating kinase activity.";
RL   J. Biol. Chem. 276:37459-37471(2001).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-241, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=15302935; DOI=10.1073/pnas.0404720101;
RA   Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,
RA   Li J., Cohn M.A., Cantley L.C., Gygi S.P.;
RT   "Large-scale characterization of HeLa cell nuclear phosphoproteins.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-245, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-241, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Pituitary;
RX   PubMed=16807684; DOI=10.1007/s11102-006-8916-x;
RA   Beranova-Giorgianni S., Zhao Y., Desiderio D.M., Giorgianni F.;
RT   "Phosphoproteomic analysis of the human pituitary.";
RL   Pituitary 9:109-120(2006).
RN   [14]
RP   INTERACTION WITH NPRL2.
RX   PubMed=18616680; DOI=10.1111/j.1349-7006.2008.00874.x;
RA   Kurata A., Katayama R., Watanabe T., Tsuruo T., Fujita N.;
RT   "TUSC4/NPRL2, a novel PDK1-interacting protein, inhibits PDK1 tyrosine
RT   phosphorylation and its downstream signaling.";
RL   Cancer Sci. 99:1827-1834(2008).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-37 AND SER-241, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-241, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-37 AND SER-241, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-35 AND SER-241, AND MASS
RP   SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-241, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [20]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-304, AND MASS SPECTROMETRY.
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
CC   -!- FUNCTION: Phosphorylates and activates not only PKB/AKT, but also
CC       PKA, PKC-zeta, RPS6KA1 and RPS6KB1. May play a general role in
CC       signaling processes and in development (By similarity). Isoform 3
CC       is catalytically inactive.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- SUBUNIT: Interacts with NPRL2.
CC   -!- INTERACTION:
CC       Q05209:PTPN12; NbExp=1; IntAct=EBI-717097, EBI-2266035;
CC       Q9Y2R2:PTPN22; NbExp=1; IntAct=EBI-717097, EBI-1211241;
CC       P23467:PTPRB; NbExp=1; IntAct=EBI-717097, EBI-1265766;
CC       P08575:PTPRC; NbExp=1; IntAct=EBI-717097, EBI-1341;
CC       P23470:PTPRG; NbExp=1; IntAct=EBI-717097, EBI-2258115;
CC       Q12913:PTPRJ; NbExp=1; IntAct=EBI-717097, EBI-2264500;
CC       Q15262:PTPRK; NbExp=1; IntAct=EBI-717097, EBI-474052;
CC       Q16827:PTPRO; NbExp=1; IntAct=EBI-717097, EBI-723739;
CC       O00141:SGK1; NbExp=1; IntAct=EBI-717097, EBI-1042854;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Membrane; Peripheral membrane
CC       protein. Note=Membrane-associated after cell stimulation leading
CC       to its translocation. Tyrosine phosphorylation seems to occur only
CC       at the plasma membrane.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=O15530-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O15530-2; Sequence=VSP_004894;
CC       Name=3;
CC         IsoId=O15530-3; Sequence=VSP_004895;
CC   -!- TISSUE SPECIFICITY: Appears to be expressed ubiquitously.
CC   -!- PTM: Phosphorylated on tyrosine and serine/threonine.
CC       Phosphorylation on Ser-241 in the activation loop is required for
CC       full activity. PDK1 itself can autophosphorylate Ser-241, leading
CC       to its own activation.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr
CC       protein kinase family. PDK1 subfamily.
CC   -!- SIMILARITY: Contains 1 PH domain.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF017995; AAC51825.1; -; mRNA.
DR   EMBL; Y15056; CAA75341.1; -; mRNA.
DR   EMBL; CR536517; CAG38755.1; -; mRNA.
DR   EMBL; BC012103; AAH12103.1; -; mRNA.
DR   IPI; IPI00002538; -.
DR   IPI; IPI00216646; -.
DR   IPI; IPI00216647; -.
DR   RefSeq; NP_002604.1; -.
DR   RefSeq; NP_112558.2; -.
DR   UniGene; Hs.459691; -.
DR   PDB; 1H1W; X-ray; 2.00 A; A=71-359.
DR   PDB; 1OKY; X-ray; 2.30 A; A=51-360.
DR   PDB; 1OKZ; X-ray; 2.51 A; A=51-360.
DR   PDB; 1UU3; X-ray; 1.70 A; A=51-360.
DR   PDB; 1UU7; X-ray; 1.90 A; A=51-360.
DR   PDB; 1UU8; X-ray; 2.50 A; A=51-360.
DR   PDB; 1UU9; X-ray; 1.95 A; A=72-357.
DR   PDB; 1UVR; X-ray; 2.81 A; A=71-359.
DR   PDB; 1W1D; X-ray; 1.50 A; A=409-556.
DR   PDB; 1W1G; X-ray; 1.45 A; A=409-556.
DR   PDB; 1W1H; X-ray; 1.45 A; A/B/C/D=409-556.
DR   PDB; 1Z5M; X-ray; 2.17 A; A=74-359.
DR   PDB; 2BIY; X-ray; 1.95 A; A=51-360.
DR   PDB; 2PE0; X-ray; 2.35 A; A=74-359.
DR   PDB; 2PE1; X-ray; 2.14 A; A=74-359.
DR   PDB; 2PE2; X-ray; 2.13 A; A=74-359.
DR   PDB; 2R7B; X-ray; 2.70 A; A=48-359.
DR   PDB; 2VKI; X-ray; 1.80 A; A=409-556.
DR   PDB; 2XCH; X-ray; 2.00 A; A=51-359.
DR   PDB; 2XCK; X-ray; 2.30 A; A=51-359.
DR   PDB; 3H9O; X-ray; 2.30 A; A=51-359.
DR   PDB; 3HRC; X-ray; 1.91 A; A=50-359.
DR   PDB; 3HRF; X-ray; 1.90 A; A=50-359.
DR   PDB; 3ION; X-ray; 2.40 A; A=48-359.
DR   PDB; 3IOP; X-ray; 2.20 A; A=48-359.
DR   PDBsum; 1H1W; -.
DR   PDBsum; 1OKY; -.
DR   PDBsum; 1OKZ; -.
DR   PDBsum; 1UU3; -.
DR   PDBsum; 1UU7; -.
DR   PDBsum; 1UU8; -.
DR   PDBsum; 1UU9; -.
DR   PDBsum; 1UVR; -.
DR   PDBsum; 1W1D; -.
DR   PDBsum; 1W1G; -.
DR   PDBsum; 1W1H; -.
DR   PDBsum; 1Z5M; -.
DR   PDBsum; 2BIY; -.
DR   PDBsum; 2PE0; -.
DR   PDBsum; 2PE1; -.
DR   PDBsum; 2PE2; -.
DR   PDBsum; 2R7B; -.
DR   PDBsum; 2VKI; -.
DR   PDBsum; 2XCH; -.
DR   PDBsum; 2XCK; -.
DR   PDBsum; 3H9O; -.
DR   PDBsum; 3HRC; -.
DR   PDBsum; 3HRF; -.
DR   PDBsum; 3ION; -.
DR   PDBsum; 3IOP; -.
DR   ProteinModelPortal; O15530; -.
DR   IntAct; O15530; 16.
DR   MINT; MINT-203926; -.
DR   STRING; O15530; -.
DR   PhosphoSite; O15530; -.
DR   PRIDE; O15530; -.
DR   Ensembl; ENST00000342085; ENSP00000344220; ENSG00000140992.
DR   GeneID; 5170; -.
DR   KEGG; hsa:5170; -.
DR   UCSC; uc002cqs.1; human.
DR   CTD; 5170; -.
DR   GeneCards; GC16P002527; -.
DR   H-InvDB; HIX0202289; -.
DR   HGNC; HGNC:8816; PDPK1.
DR   HPA; CAB004272; -.
DR   MIM; 605213; gene.
DR   PharmGKB; PA33160; -.
DR   eggNOG; prNOG14283; -.
DR   HOGENOM; HBG755340; -.
DR   HOVERGEN; HBG098357; -.
DR   InParanoid; O15530; -.
DR   OMA; HLQTPPK; -.
DR   OrthoDB; EOG9Z390V; -.
DR   PhylomeDB; O15530; -.
DR   BRENDA; 2.7.11.1; 247.
DR   Pathway_Interaction_DB; bcr_5pathway; BCR signaling pathway.
DR   Pathway_Interaction_DB; pi3kcipathway; Class I PI3K signaling events.
DR   Pathway_Interaction_DB; pi3kciaktpathway; Class I PI3K signaling events mediated by Akt.
DR   Pathway_Interaction_DB; fgf_pathway; FGF signaling pathway.
DR   Pathway_Interaction_DB; igf1_pathway; IGF1 pathway.
DR   Pathway_Interaction_DB; insulin_pathway; Insulin Pathway.
DR   Pathway_Interaction_DB; mtor_4pathway; mTOR signaling pathway.
DR   Pathway_Interaction_DB; met_pathway; Signaling events activated by Hepatocyte Growth Factor Receptor (c-Met).
DR   Pathway_Interaction_DB; kitpathway; Signaling events mediated by Stem cell factor receptor (c-Kit).
DR   Pathway_Interaction_DB; vegfr1_2_pathway; Signaling events mediated by VEGFR1 and VEGFR2.
DR   Pathway_Interaction_DB; tcrpathway; TCR signaling in naive CD4+ T cells.
DR   Pathway_Interaction_DB; cd8tcrpathway; TCR signaling in naive CD8+ T cells.
DR   Pathway_Interaction_DB; tgfbrpathway; TGF-beta receptor signaling.
DR   Pathway_Interaction_DB; pi3kplctrkpathway; Trk receptor signaling mediated by PI3K and PLC-gamma.
DR   Pathway_Interaction_DB; vegfr1_pathway; VEGFR1 specific signals.
DR   Reactome; REACT_11061; Signalling by NGF.
DR   Reactome; REACT_13685; Synaptic Transmission.
DR   Reactome; REACT_14797; Signaling by GPCR.
DR   Reactome; REACT_498; Signaling by Insulin receptor.
DR   Reactome; REACT_604; Hemostasis.
DR   Reactome; REACT_6900; Signaling in Immune system.
DR   DrugBank; DB00482; Celecoxib.
DR   NextBio; 20004; -.
DR   ArrayExpress; O15530; -.
DR   Bgee; O15530; -.
DR   CleanEx; HS_PDK1; -.
DR   CleanEx; HS_PDPK1; -.
DR   Genevestigator; O15530; -.
DR   GermOnline; ENSG00000140992; Homo sapiens.
DR   GO; GO:0005829; C:cytosol; EXP:Reactome.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0004676; F:3-phosphoinositide-dependent protein kinase...; IDA:BHF-UCL.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005515; F:protein binding; IPI:UniProtKB.
DR   GO; GO:0030036; P:actin cytoskeleton organization; TAS:ProtInc.
DR   GO; GO:0032148; P:activation of protein kinase B activity; IDA:BHF-UCL.
DR   GO; GO:0032869; P:cellular response to insulin stimulus; IMP:BHF-UCL.
DR   GO; GO:0023034; P:intracellular signaling pathway; IDA:MGI.
DR   GO; GO:0006469; P:negative regulation of protein kinase activity; IDA:BHF-UCL.
DR   GO; GO:0018107; P:peptidyl-threonine phosphorylation; IDA:BHF-UCL.
DR   GO; GO:0090004; P:positive regulation of establishment of pro...; IMP:BHF-UCL.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR011993; PH_type.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR015746; Ser/Thr_kinase_PInositide-dep.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   Gene3D; G3DSA:2.30.29.30; PH_type; 2.
DR   PANTHER; PTHR22985:SF93; PK1_3-phosphoinositide; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS50003; PH_DOMAIN; FALSE_NEG.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding;
KW   Complete proteome; Cytoplasm; Direct protein sequencing; Kinase;
KW   Membrane; Nucleotide-binding; Phosphoprotein;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    556       3-phosphoinositide-dependent protein
FT                                kinase 1.
FT                                /FTId=PRO_0000086500.
FT   DOMAIN       82    342       Protein kinase.
FT   DOMAIN      459    550       PH.
FT   NP_BIND      88     96       ATP (By similarity).
FT   COMPBIAS    389    398       Poly-Ser.
FT   ACT_SITE    205    205       Proton acceptor (By similarity).
FT   BINDING     111    111       ATP (By similarity).
FT   MOD_RES       9      9       Phosphotyrosine.
FT   MOD_RES      25     25       Phosphoserine.
FT   MOD_RES      35     35       Phosphoserine.
FT   MOD_RES      37     37       Phosphothreonine.
FT   MOD_RES     241    241       Phosphoserine; by autocatalysis.
FT   MOD_RES     245    245       Phosphothreonine.
FT   MOD_RES     304    304       N6-acetyllysine.
FT   MOD_RES     373    373       Phosphotyrosine.
FT   MOD_RES     376    376       Phosphotyrosine.
FT   MOD_RES     393    393       Phosphoserine.
FT   MOD_RES     396    396       Phosphoserine.
FT   MOD_RES     410    410       Phosphoserine.
FT   VAR_SEQ       1     50       Missing (in isoform 2).
FT                                /FTId=VSP_004894.
FT   VAR_SEQ     238    263       Missing (in isoform 3).
FT                                /FTId=VSP_004895.
FT   MUTAGEN       9      9       Y->F: Slight reduction in pervanadate-
FT                                stimulated tyrosine phosphorylation.
FT   MUTAGEN      25     25       S->A: No effect.
FT   MUTAGEN     241    241       S->A: No activation.
FT   MUTAGEN     277    277       A->V: 3-fold increase in kinase activity.
FT   MUTAGEN     373    373       Y->F: Reduction in basal activity.
FT   MUTAGEN     376    376       Y->F: Reduction in basal activity.
FT   MUTAGEN     393    393       S->A: No effect.
FT   MUTAGEN     396    396       S->A: No effect.
FT   MUTAGEN     410    410       S->A: No effect.
FT   MUTAGEN     474    474       R->A: No PDGF-dependent translocation to
FT                                the membrane.
FT   HELIX        79     81
FT   STRAND       82     90
FT   STRAND       95    101
FT   TURN        102    104
FT   STRAND      107    114
FT   HELIX       115    120
FT   HELIX       124    136
FT   STRAND      145    150
FT   STRAND      152    159
FT   HELIX       167    174
FT   HELIX       179    198
FT   TURN        208    210
FT   STRAND      211    213
FT   STRAND      219    221
FT   HELIX       246    248
FT   HELIX       251    255
FT   HELIX       261    277
FT   HELIX       287    295
FT   HELIX       307    314
FT   HELIX       321    323
FT   HELIX       328    330
FT   HELIX       333    337
FT   HELIX       340    342
FT   HELIX       350    352
FT   HELIX       412    415
FT   STRAND      416    420
FT   STRAND      423    426
FT   HELIX       432    445
FT   HELIX       449    451
FT   TURN        452    454
FT   STRAND      457    467
FT   STRAND      470    479
FT   TURN        480    482
FT   STRAND      483    488
FT   TURN        489    492
FT   STRAND      493    498
FT   STRAND      505    518
FT   STRAND      521    526
FT   HELIX       532    547
SQ   SEQUENCE   556 AA;  63152 MW;  ED8C0306DC4D0653 CRC64;
     MARTTSQLYD AVPIQSSVVL CSCPSPSMVR TQTESSTPPG IPGGSRQGPA MDGTAAEPRP
     GAGSLQHAQP PPQPRKKRPE DFKFGKILGE GSFSTVVLAR ELATSREYAI KILEKRHIIK
     ENKVPYVTRE RDVMSRLDHP FFVKLYFTFQ DDEKLYFGLS YAKNGELLKY IRKIGSFDET
     CTRFYTAEIV SALEYLHGKG IIHRDLKPEN ILLNEDMHIQ ITDFGTAKVL SPESKQARAN
     SFVGTAQYVS PELLTEKSAC KSSDLWALGC IIYQLVAGLP PFRAGNEYLI FQKIIKLEYD
     FPEKFFPKAR DLVEKLLVLD ATKRLGCEEM EGYGPLKAHP FFESVTWENL HQQTPPKLTA
     YLPAMSEDDE DCYGNYDNLL SQFGCMQVSS SSSSHSLSAS DTGLPQRSGS NIEQYIHDLD
     SNSFELDLQF SEDEKRLLLE KQAGGNPWHQ FVENNLILKM GPVDKRKGLF ARRRQLLLTE
     GPHLYYVDPV NKVLKGEIPW SQELRPEAKN FKTFFVHTPN RTYYLMDPSG NAHKWCRKIQ
     EVWRQRYQSH PDAAVQ
//
